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Introduction: Fasting of Ramadan is a religious obligation that is prac-
ticed by the Muslim population in the world. However, there is a lack of sci-
entific literature regarding the effects on cardiovascular disorders such as
hypertension.
Objective: This study was conducted to assess the impact of Ramadan
fasting on blood pressure in treated hypertensive patients.
Materials and Methods: This prospective observational trial was
conducted on 18 patients treated for hypertension, who were determined to
end the fast of Ramadan. All subjects were on antihypertensive therapy. Mea-
surements of blood pressure was performed by Holter blood pressure before
and after the month of Ramadan.
Results: The mean age of subjects was 57.61±12.64 years; with a female
predominance. There was a significant decrease in average diastolic 24-h
ambulatory blood pressure, as well as average diastolic awake ambulatory
blood pressure after Ramadan (70,72±9,24mmHg vs 65,06±8,23mmHg,
P=0,01 et 73,72 ± 10,10mmHg vs 70,06 ± 9,43mmHg, P=0,01). Average sys-
tolic 24-h ambulatory blood pressure, as well as average awake systolic and
average asleep systolic and diastolic ambulatory blood pressure was similar
before and after Ramadan (125,50 ± 11,62mmHg vs 122,94 ± 10,09mmHg,
P=0,08 ; 128,44 ± 12,19mmHg vs 126,11 ± 10,80mmHg, P=0,06 ; 120,67±
13,20mmHg vs 119,83 ± 13,76mmHg, P=0,73 ; 65,72 ± 8,84mmHg vs 65,72
± 8,84mmHg, P=0,81).
Conclusion: We conclude that, according to our results, hypertensive
patients can continue their treatment as the traditional fasting during Ramadan
can be performed safely.
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Introduction: Hypertension is frequently associated with diabetes mellitus
and is responsible for an increase in the cardiovascular risk in diabetic
patients. Thus, early diagnosis and good control are of paramount importance.
Patients and Methods: This is a prospective study on 5 months of known
and treated patients diabetics, collected in non-invasive investigation unit of
the cardiology department of the CHU Ibn Rochd of Casablanca for a ABPM
whether in the diagnosis of hypertension, either as part of the monitoring of
therapeutic efficacy of known and treated hypertensive patients.
Results: The study was conducted in 75 patients (34 men and 41 women;
sex ratio: 0.77) with a mean age of 69.0 ± 3.1 years (42-77 ans).
Of a total of 36 patients with hypertension: ABPM revealed hypertension
well controlled in 52.8% of cases, uncontrolled hypertension in 38.9% of
which 71.4% was masked hypertension. The discrepancy was found
dans36,1% of cases.
Subjects with poorly controlled hypertension were significantly older
(p=0.01) and more likely to be male (p = 0.002).
Of a total of 39 patients unknown hypertension, ABPM was diagnosed
with hypertension in 46.2% of which 50% was masked hypertension. 53.8%
were normotensive. The discrepancy between the clinic BP measurement and
ABPM was of 38,5%.
Night dysregulation of BP was statistically different between the both of
groups (not hypertensive and hypertensive well controlled on one hand and
hypertension, uncontrolled other) respectively (53.8% and 46.2%, p = 0,04,
OR:2.6, CI: 1.07 to 6.8). The dippers patients have less micro-macroangio-
pathy with a p <0.05.
Conclusion: Hypertension of our patients is often poorly controlled.
Through this work, the ABPM proves interesting in diabetics in the diag-
nostic, therapeutic adaptation and assessment of prognosis.
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Resistance arteries control local blood flow. Chronic increases in blood
flow in RA occur in growth, pregnancy, exercising as well as to compensate
ischemia and induce outward hypertrophic remodeling associated with
improved endothelium dilation. As estrogens have a key role in flow-mediated
remodeling, we hypothesized that resveratrol, suggested to act as phyto-
estrogen, may improve flow-mediated remodeling in ovariectomized rats.
Blood flow was increased in vivo in one mesenteric resistance artery
without other changes in pressure or circulating factors in three-month old
ovariectomized female rats treated with resveratrol (5 or 37.5mg/kg per day in
osmotic minipumps: RESV5 or RESV37.5) or solvent (DMSO). After
2 weeks arterial structure and function were measured in vitro.
Arterial diameter increased in high flow (HF) compared to normal flow
(NF) arteries in ovariectomized rats treated with RESV5 or RESV37.5, not in
control rats. Hypertrophy in HF arteries occurred in the 3 groups but was
greater in RESV37.5-treated rats so that wall / lumen ratio was elevated in this
group. ERK1/2 activation, involved in flow-mediated hypertrophy was greater
in RESV37.5-treated rats than in RESV5 – and DMSO-treated rats. RESV5,
not RESV37.5, improved L-NAME sensitive arterial relaxation. eNOS expres-
sion level was equivalent in HF and NF vessels in all groups animals. Markers
of oxidative stress (p67phox, GP91phox) were greater in arteries of
RESV37.5-treated rats than in RESV5 – and solvent-treated rats. They were
also higher in HF arteries in RESV37.5-treated rats.
Thus, although resveratrol improved flow-mediated outward hypertrophic
remodeling in OVX rats, the high dose induced oxidative stress and hypertrophy.
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Introduction: Hypertension and dyslipidaemia are important components
of metabolic syndrome and both are known to complicate each other. The
multiplicative effect of these risk factors increases the risk of cardiovascular
disease. The aim of this study was to determine the prevalence of dyslipidemia
in hypertensive patients.
Methods: This prospective study was done in the University hospital IBN
ROCHD in Casablanca, comparing 90 hypertensive patients and 90 normoten-
sive patients controls matched for age and sex, for a period of one year from
January 2013 to January 2014. In both groups were measured the total blood
levels of cholesterol (TC), high density lipoprotein (HDL), low density lipopro-
tein (LDL) and triglycerides (TG). The exclusion criteria were previous history
of diabetes, cigarette smoking, regular alcohol use, nephropathy and hyperuri-
cemia.
April 02nd, Thursday 2015
